Everyone now "has all rights to use DR-70 at no cost to them" because DR-70 is now off patent.
I don't know whether Gartner is an Executive VP at Provista or what that title even means but none of that matters. Who cares why Gartner started up GCDx or why he stepped down as Provista CEO or why Provista dropped the lung cancer test? The fact is:
DR-70 is currently off patent. Anyone can manufacture and sell DR-70 now without paying any royalties or fees or payments to Radient.
That one fact kills the Radient takeover rumor. Or at least it should -- the Radient takeover rumor seems to be immortal. Facts don't kill it and logic doesn't kill it.
What silver bullet will kill the Radient Takeover Rumor? I am fascinated by this. The patent rejection should have been enough. Add all these bullets:
-> Gartner states that he has no professional or personal relationship with Radient.
-> MacLellan states that he left all his management positions with Radient in April and has not communicated with them since.
-> Provista states that none of their diagnostics use DR-70.
-> GCDx is actively moving forward with their business plan to sell DR-70 without any merger or takeover.
-> UNI is manufacturing and selling DR-70 in Asia while Radient lies dormant.
-> Radient management said in their last 8k that Radient is insolvent (after three years of alleged reverse merger activity).
That's a lot of silver bullets, yet the Takeover Rumor lives on. Fascinating.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.